These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23439301)

  • 1. Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.
    Molleston JP; Mellman W; Narkewicz MR; Balistreri WF; Gonzalez-Peralta RP; Jonas MM; Lobritto SJ; Mohan P; Murray KF; Njoku D; Rosenthal P; Barton BA; Talor MV; Cheng I; Schwarz KB; Haber BA;
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):304-10. PubMed ID: 23439301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.
    Rosen I; Kori M; Eshach Adiv O; Yerushalmi B; Zion N; Shaoul R
    World J Gastroenterol; 2013 Feb; 19(7):1098-103. PubMed ID: 23467199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
    Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
    Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
    Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial.
    Jiménez-Luévano MÁ; Lerma-Díaz JM; Hernández-Flores G; Jiménez-Partida MÁ; Bravo-Cuellar A
    Ann Hepatol; 2013; 12(2):248-55. PubMed ID: 23396736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin.
    Todorovska B; Joksimovic N; Caloska-Ivanova V; Dimitrova-Genadieva M; Trajkovska M; Curakova E; Kiprijanovska S; Zafirova-Ivanovska B; Serafimoski V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):25-33. PubMed ID: 28593897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmune hepatitis and membranous glomerulonephritis under immune therapy in chronic hepatitis C].
    Paparoupa M; Huy Ho NA; Schuppert F
    Dtsch Med Wochenschr; 2016 May; 141(10):709-11. PubMed ID: 27176065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune thyroiditis and delayed onset psoriasis in association with combination therapy for chronic hepatitis C infection.
    Chong VH
    Singapore Med J; 2011 Feb; 52(2):e20-2. PubMed ID: 21373724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: results of a prospective single-centre study.
    Berak H; Laskus T; Kołakowska-Rządzka A; Wasilewski M; Stańczak JJ; Bardadin K; Walewska-Zielecka B; Horban A
    Adv Med Sci; 2014 Sep; 59(2):261-5. PubMed ID: 25117425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.
    Schwarz KB; Gonzalez-Peralta RP; Murray KF; Molleston JP; Haber BA; Jonas MM; Rosenthal P; Mohan P; Balistreri WF; Narkewicz MR; Smith L; Lobritto SJ; Rossi S; Valsamakis A; Goodman Z; Robuck PR; Barton BA;
    Gastroenterology; 2011 Feb; 140(2):450-458.e1. PubMed ID: 21036173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.
    Alsaran K; Sabry A; Shaheen N
    Int Urol Nephrol; 2011 Sep; 43(3):865-73. PubMed ID: 20490669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha.
    Gehring S; Kullmer U; Koeppelmann S; Gerner P; Wintermeyer P; Wirth S
    World J Gastroenterol; 2006 Sep; 12(36):5787-92. PubMed ID: 17007043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
    Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R
    Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C.
    Pavan MH; Pavin EJ; Gonçales FL; Zantut-Wittmann DE; Wittmann DE
    Braz J Infect Dis; 2011; 15(5):449-56. PubMed ID: 22230851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
    Di Bisceglie AM; Janczweska-Kazek E; Habersetzer F; Mazur W; Stanciu C; Carreno V; Tanasescu C; Flisiak R; Romero-Gomez M; Fich A; Bataille V; Toh ML; Hennequi M; Zerr P; Honnet G; Inchauspé G; Agathon D; Limacher JM; Wedemeyer H
    Gastroenterology; 2014 Jul; 147(1):119-131.e3. PubMed ID: 24657484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
    Vabo IL; Ferreira LE; Pace FH
    Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection.
    Haber B; Alonso E; Pedreira A; Rodriguez-Baez N; Ciocca M; Lacaille F; Lang T; Gonzalez T; Goodman Z; Yang Z; Jackson B; Noviello S; Albrecht JK
    J Pediatr Gastroenterol Nutr; 2017 Jan; 64(1):89-94. PubMed ID: 27111344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
    Chung RT; Andersen J; Volberding P; Robbins GK; Liu T; Sherman KE; Peters MG; Koziel MJ; Bhan AK; Alston B; Colquhoun D; Nevin T; Harb G; van der Horst C;
    N Engl J Med; 2004 Jul; 351(5):451-9. PubMed ID: 15282352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.